| Mai Mohsen, | |
|
11450 San Pablo Ave, El Cerrito, CA 94530-1917 | |
| (510) 233-8400 | |
| Not Available |
| Full Name | Mai Mohsen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 11450 San Pablo Ave, El Cerrito, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033546544 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 69105 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mai Mohsen, 330 Crescent Village Cir Unit 2321, San Jose, CA 95134-3557 Ph: (408) 646-6723 | Mai Mohsen, 11450 San Pablo Ave, El Cerrito, CA 94530-1917 Ph: (510) 233-8400 |
News Archive
The spread, or metastasis, of individual breast cancer cells from the main tumor into the blood circulation to the lungs and other body tissues and organs is under the control of a growth factor abbreviated TGFb, according to a study with laboratory mice that will be presented at the American Society for Cell Biology (ASCB) 49th Annual Meeting, Dec. 5-9, 2009 in San Diego.
New research on deaths from cancer in Europe concludes that the key priority for continuing to reduce mortality is cutting tobacco smoking. The study shows that, while deaths for men from lung cancer in the EU have declined overall, by 17 % from 1995 to 2004, they rose by 27% for women over the same period.
Biofield Corp. announced today that its 51% owned subsidiary, Sky Unicorn Holdings Ltd., has engaged McKinley Infocapital as its exclusive distributor in Korea for its flagship product, the Biofield Breast Diagnostic System (BDS). McKinley Infocapital, an international business consulting and investment management firm, has formed MacKay Life Sciences Korea to market and promote the BDS in Korea.
The Pennsylvania Trauma Systems Foundation (PTSF) Board of Directors has released a white paper outlining recommendations for development of trauma centers in Pennsylvania moving into the future.
Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration has accepted for review a Supplemental New Drug Application for Eliquis (apixaban), for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism, in adult patients who have undergone hip or knee replacement surgery.
› Verified 5 days ago
Preetinder Kaur Virk, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 El Cerrito Plz, El Cerrito, CA 94530 Phone: 510-524-5895 | |
Amy Ng, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11565 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-234-9300 | |
Thanh-tam Le, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6641 Gatto Ave, El Cerrito, CA 94530 Phone: 704-383-0119 | |
Sarah Mashreky, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10650 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-527-3210 | |
Liv Larson, PHARMD0 Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11565 San Pablo Ave, El Cerrito, CA 94530 Phone: 510-234-9300 | |
Diana Treadway, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10650 San Pablo Ave, El Cerrito, CA 94530 Phone: 520-527-3210 |